4D Advisors LLC Invests $3.92 Million in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

4D Advisors LLC bought a new position in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 85,000 shares of the company's stock, valued at approximately $3,916,000. Establishment Labs makes up about 2.7% of 4D Advisors LLC's holdings, making the stock its 16th biggest holding. 4D Advisors LLC owned 0.30% of Establishment Labs as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Quarry LP purchased a new stake in shares of Establishment Labs during the 4th quarter valued at $27,000. R Squared Ltd bought a new position in Establishment Labs during the fourth quarter valued at about $36,000. Federated Hermes Inc. raised its position in Establishment Labs by 3.0% in the fourth quarter. Federated Hermes Inc. now owns 32,720 shares of the company's stock worth $1,507,000 after acquiring an additional 953 shares during the period. Swiss National Bank raised its position in Establishment Labs by 2.7% in the fourth quarter. Swiss National Bank now owns 38,500 shares of the company's stock worth $1,774,000 after acquiring an additional 1,000 shares during the period. Finally, Handelsbanken Fonder AB boosted its stake in Establishment Labs by 32.3% in the fourth quarter. Handelsbanken Fonder AB now owns 8,200 shares of the company's stock valued at $378,000 after acquiring an additional 2,000 shares during the last quarter. Hedge funds and other institutional investors own 72.91% of the company's stock.

Establishment Labs Stock Performance

ESTA traded down $0.07 on Wednesday, hitting $32.96. The company's stock had a trading volume of 188,659 shares, compared to its average volume of 462,140. The company's 50 day simple moving average is $35.43 and its 200-day simple moving average is $38.73. The company has a quick ratio of 2.29, a current ratio of 3.62 and a debt-to-equity ratio of 5.94. Establishment Labs Holdings Inc. has a 12 month low of $26.56 and a 12 month high of $60.12. The firm has a market cap of $950.62 million, a P/E ratio of -12.81 and a beta of 0.73.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The company reported ($0.98) earnings per share for the quarter, missing the consensus estimate of ($0.64) by ($0.34). Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. The company had revenue of $44.51 million during the quarter, compared to analysts' expectations of $44.45 million. Analysts forecast that Establishment Labs Holdings Inc. will post -2.41 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms recently commented on ESTA. Stephens reaffirmed an "overweight" rating and issued a $52.00 price target on shares of Establishment Labs in a report on Thursday, March 6th. Needham & Company LLC began coverage on Establishment Labs in a research report on Monday, April 14th. They set a "hold" rating on the stock. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $57.40.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.